The Emcure Pharma IPO started on July 3, 2024, and ended on July 5, 2024. Shares were allocated on July 8, 2024, and refund processes began on July 9, 2024. On July 9, 2024, the shares were credited to investors demat accounts. Emcure Pharma was officially listed on the stock exchange on July 10, 2024.
During the IPO, Emcure Pharma offered shares at a price range of ₹960 to ₹1008 per share, and the lot size was 14 shares. The total size of Emcure Pharma IPO is ₹1,952.03 crores out of which ₹800.00 crores is fresh issue and ₹1,152.03 crores is offer for sale (OFS). The IPO was listed on the NSE and BSE.
Regarding share reservations, 50% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 35% were set aside for retail investors.
Emcure Pharma IPO Subscription Update Video
Emcure Pharma IPO Subscription Status
The Emcure Pharma IPO on July 5, 2024 was subscribed 67.87 times, with the retail category being subscribed 7.36 times, the NII (Non-Institutional Investor) category being subscribed 49.32 times, the QIB (Qualified-Institutional Buyers) category being subscribed 191.24 times and the Employee category being subscribed 8.81 times.
| Category | Subscription |
| QIB | 191.24x |
| NII | 49.32x |
| Retail | 7.36x |
| Employee | 8.81x |
| Total | 67.87x |
Emcure Pharma IPO Basic Details
| Company Name | Emcure Pharmaceuticals Limited |
| Domain of Company | Pharma Company |
| Aasaan Loans IPO Open Date | July 3, 2024 |
| Aasaan Loans IPO Close Date | July 5, 2024 |
| Aasaan Loans IPO Allotment Date | July 8, 2024 |
| Aasaan Loans IPO Listing Date | July 10, 2024 |
| Face Value | ₹10 per share |
| Price | ₹960 to ₹1008 per share |
| Lot Size | 14 Shares |
| Issue Size | 9,365,346 shares of ₹10 (aggregating up to ₹1,952.03 Cr) |
| Fresh Issue | 7,936,507 shares of ₹10 (aggregating up to ₹800.00 Cr) |
| Offer for Sale | 11,428,839 shares of ₹10 (aggregating up to ₹1,152.03 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE, BSE |
| Company Promoters | Satish Mehta and Sunil Mehta |
About Emcure Pharmaceuticals Limited
Founded in 1981, Emcure Pharmaceuticals Limited is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing a wide range of pharmaceutical products worldwide, covering major therapeutic areas.
Market Position and Achievements
As of September 2023, Emcure ranks 13th in domestic sales among Indian pharmaceutical companies and holds the 4th largest market share in its covered markets. It is the top pharmaceutical company in gynecology and HIV antiviral treatments for the same period.
Revenue and Growth
In the first half of 2023 and the financial year 2023, domestic sales contributed 50.84% and 53.16% of Emcure’s total revenue, respectively. The company’s domestic sales have grown at a compound annual growth rate (CAGR) of 10.80% between September 2019 and September 2023, outperforming the overall Indian pharmaceutical market.
Research and Development
As of September 30, 2023, Emcure employs 552 scientists and operates five research facilities in India. The company has filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. Emcure holds 201 granted patents, has 33 pending patent applications, and has submitted 102 drug master files.
Manufacturing Capabilities
Emcure operates 13 manufacturing facilities across India, capable of producing a variety of pharmaceutical and biopharmaceutical products, such as pills, liquids, injectables, and complex ingredients like chiral molecules, iron molecules, and cytotoxic substances.
Marketing and Distribution
As of September 30, 2023, Emcure’s marketing and distribution network in India includes over 5,000 field personnel who regularly engage with healthcare providers. The distribution network consists of more than 5,000 stockists, supported by 37 carry-and-forward agents.
Emcure Pharma IPO Should you subscribe?
Emcure Pharma IPO More Details Click Here
Emcure Pharma IPO FAQs
What is the start and end date of Emcure Pharma IPO Subscription?
The Emcure Pharma IPO started on July 3, 2024, and ended on July 5, 2024.
When does Emcure Pharma IPO Subscription open?
The Emcure Pharma IPO open on July 3, 2024.
When does Emcure Pharma IPO Subscription close?
The Emcure Pharma IPO Close on July 5, 2024.
What is the allotment date of Emcure Pharma IPO?
The allotment date for Emcure Pharma IPO is July 8, 2024.
When is the initial refund date of Emcure Pharma IPO?
The initial Refund date for Emcure Pharma IPO is July 9, 2024.
When were the shares credited to investors demat accounts for the Emcure Pharma IPO?
The shares for the Emcure Pharma IPO were credited to investors demat accounts on July 9, 2024.
When will Emcure Pharma IPO be listed on the stock market?
Emcure Pharma IPO stock market will be listed on July 10, 2024 at 10 am.
What was the price range of the Emcure Pharma IPO shares?
The Emcure Pharma IPO shares were offered at a price range of ₹960 to ₹1008 per share.
What was the lot size for the Emcure Pharma IPO shares?
The lot size for the Emcure Pharma IPO shares was 14 shares.
What was the total issue size of the Emcure Pharma IPO?
The total issue size of the Emcure Pharma IPO was ₹1,952.03 crores.
How were the shares allocated among different types of investors for the Emcure Pharma IPO?
50% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 35% were set aside for retail investors.
On which stock exchanges was the Emcure Pharma IPO listed?
The Emcure Pharma IPO was listed on both the NSE and BSE.
What is the Emcure Pharma IPO Subscription Status?
Emcure Pharma IPO is subscribed 67.87 Times.
